11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Annual Meeting Results: Six Directors Elected at Cardiff Oncology, Inc.
Investor Presentation
Cardiff Oncology, Inc. Sues NMS Over License Agreement Dispute
Other Events
Reports First Quarter 2026 Results and Provides Business Update
Annual Report to Security Holders
Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
Material disclosure
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload